The nine novel candidates include PPARG, a nuclear receptor involved in differentiation and metabolism and implicated in cancer progression [44,45]; MMP10, which promotes tumor invasion via extracellular matrix degradation [46]; and the long noncoding RNAs CASC11 and CCAT2, both regulators of Wnt/β-catenin and MYC signaling pathways [47,48,49,50]. The gene discussed is MYC; the disease is neoplasm.